CLIK
You are here
A drug from the specified list
Retinal vascular occlusive disease - A drug from the specified list Factor
Last reviewed for CCPS 05 October 2006.
Investigative Documents
Claimant Report - Use of a Specified Drug [CR9265] Medical Report - Use of a Specified Drug [MR9344] Preliminary questions [36281]
36329 the veteran used a drug from the specified list for retinal vascular occlusive disease within the 72 hours before the clinical onset of retinal vascular occlusive disease. 36330 — the veteran has established the causal connection between using a drug from the specifed list for retinal vascular occlusive disease and VEA service for the clinical onset of retinal vascular occlusive disease. 36331 — the veteran has established the causal connection between using a drug from the specifed list for retinal vascular occlusive disease and operational service for the clinical onset of retinal vascular occlusive disease. or 36332 — the veteran has established the causal connection between using a drug from the specifed list for retinal vascular occlusive disease and eligible service for the clinical onset of retinal vascular occlusive disease. Clinical onset and operational service [36331] or 36336 — the identified illness or injury, as a consequence of which the veteran used a drug from the specified list for retinal vascular occlusive disease within the 72 hours before the clinical onset of retinal vascular occlusive disease, is causally related to operational service. Clinical onset and eligible service [36332] or
36337 — the identified illness or injury, as a consequence of which the veteran used a drug from the specified list for retinal vascular occlusive disease within the 72 hours before the clinical onset of retinal vascular occlusive disease, is causally related to eligible service.